FindMyRecallSubscribe
Class I: serious health riskTerminated

Matrixx Initiatives Zicam Extreme Congestion Relief Recall

Zicam Extreme Congestion Relief (oxymetazoline HCl) nasal gel, 0

Matrixx Initiatives Inc · Scottsdale, AZ

Risk level
Class I
Reported by FDA
Feb 13, 2013
Recall ID
D-155-2013
Check your lot numberHow we source this data

Summary

Matrixx Initiatives recalled Zicam Extreme Congestion Relief starting Dec 18, 2012. The FDA classified it as Class I (serious health risk) and published enforcement report D-155-2013 on Feb 13, 2013. Reason: Microbial Contamination of Non-Sterile Products: Product may be contaminated with Burkholderia cepacia. Status: Terminated.

Why it was recalled

Microbial Contamination of Non-Sterile Products: Product may be contaminated with Burkholderia cepacia.

Product description

Zicam Extreme Congestion Relief (oxymetazoline HCl) nasal gel, 0.05%, 0.50 fl. oz. (15 mL) spray bottle, Developed and distributed by Zicam LLC, Scottsdale, Arizona 85255, a wholly owned subsidiary of Matrixx Initiatives Inc, NDC 62750-005-10, UPC 7 32216 20410 0.

Lot numbers, UPCs & expiration codes

Lot # 2J23, Exp 09/15

Where it was sold

Nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-155-2013
Classification
Class I
Status
Terminated
Recall initiated
Dec 18, 2012
FDA report date
Feb 13, 2013
Quantity
46,752 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Matrixx Initiatives Inc

Original FDA data

Every field from FDA enforcement report D-155-2013, exactly as published.

Show all FDA fields
City
Scottsdale
State
AZ
Status
Terminated
Country
United States
Event ID
63917
Address
8515 E Anderson Dr
Code information
Lot # 2J23, Exp 09/15
Postal code
85255-5461
Report date
Feb 13, 2013
Product type
Drugs
Recall number
D-155-2013
Classification
Class I
Recalling firm
Matrixx Initiatives Inc
Product quantity
46,752 bottles
Termination date
Nov 14, 2013
Reason for recall
Microbial Contamination of Non-Sterile Products: Product may be contaminated with Burkholderia cepacia.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Zicam Extreme Congestion Relief (oxymetazoline HCl) nasal gel, 0.05%, 0.50 fl. oz. (15 mL) spray bottle, Developed and distributed by Zicam LLC, Scottsdale, Arizona 85255, a wholly owned subsidiary of Matrixx Initiatives Inc, NDC 62750-005-10, UPC 7 32216 20410 0.
Distribution pattern
Nationwide.
Recall initiation date
Dec 18, 2012
Initial firm notification
Press Release
Center classification date
Feb 7, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-155-2013, published Feb 13, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls